• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® EGFR MUTATION TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® EGFR MUTATION TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM Back to Search Results
Catalog Number 07248563190
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/28/2022
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
A customer from hong kong alleged discrepant results with 3 patient samples using the cobas egfr mutation test, v2.Patient 1 initially generated no mutation detected result on (b)(6) 2022.The sample was sent for ngs in 2022 which generated l858r mutation detected result.A new specimen was collected in (b)(6) 2023 and tested on (b)(6) 2023 using the cobas egfr v2 test which generated l858r mutation detected result.Patient 2 initially generated no mutaton detected on (b)(6) 2023.The sample was sent for ngs which generated e709a;g179a mutation detected result.On (b)(6) 2023, the sample was retested on the cobas egfr v2 test and generated g179x mutation detected result.Patient 3 initially generated no mutation detected result on (b)(6) 2023.The sample was repeated on the cobas egfr v2 test which generated l858r mutation detected result.
 
Manufacturer Narrative
No product problem identified.The root cause contributing to the discrepant results observed by the customer is sample/site specific such as sample at the limit of detection (lod) and/or suboptimal workflow.Note, for the patient 1 sample, the off-label sample type (pericardial fluid) was likely a contributing factor.Per the method sheet, "the cobas egfr test has been validated for use with nsclc ffpet tumor samples and plasma separated from blood collected in the roche cfdna tube or k2 edta tube.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS® EGFR MUTATION TEST V2
Type of Device
SOMATIC GENE MUTATION DETECTION SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
timothy blair
1080 us hwy 202 s
branchburg, NJ 08876
MDR Report Key18232238
MDR Text Key329914640
Report Number2243471-2023-03793
Device Sequence Number1
Product Code OWD
UDI-Device Identifier00875197005448
UDI-Public00875197005448
Combination Product (y/n)Y
Reporter Country CodeHK
PMA/PMN Number
P150047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07248563190
Device Lot NumberJ18917
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-